Moreover, a ChIP assay was performed to confirm that NCOA3 bound to TERT promoter in LO2 and HCC cells, and the results showed that NCOA3 had much stronger binding at the endogenous TERT promoter in HCC cells compared to LO2 cells (Fig. 1C). This evidence concerns the gene NCOA3 and hepatocellular carcinoma.